| C097949 | 1,25-dihydroxyvitamin D | "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]]" | 18829283 |
| C097949 | 1,25-dihydroxyvitamin D | "HRAS protein inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]" | 18829283 |
| C032041 | 1,2-diphenylhydrazine | "[Copper co-treated with 1,2-diphenylhydrazine] results in increased mutagenesis of HRAS gene" | 10798712 |
| C032041 | 1,2-diphenylhydrazine | "piperidine promotes the reaction [[Copper co-treated with 1,2-diphenylhydrazine] results in increased mutagenesis of HRAS gene]" | 10798712 |
| C031763 | 1,3-butadiene | "1,3-butadiene results in increased mutagenesis of HRAS gene" | 11397402 |
| C047777 | 1-amino-2,4-dibromoanthraquinone | "1-amino-2,4-dibromoanthraquinone results in increased mutagenesis of HRAS gene" | 11560247 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of HRAS mRNA | 11911274|9891514 |
| C032668 | 1-nitropyrene | 1-nitropyrene affects the expression of HRAS mRNA | 11201684 |
| C031903 | 1-UFT protocol | HRAS protein results in decreased susceptibility to 1-UFT protocol | 16734730 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of HRAS mRNA" | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein inhibits the reaction [1,25-dihydroxyvitamin D results in increased activity of VDR protein]]" | 18829283 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein results in increased activity of MMP2 protein] | 23877152 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased expression of ATF6 protein | 24898257 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased expression of HSPA5 protein | 24898257 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased phosphorylation of AKT1 protein | 24898257 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased phosphorylation of RPS6KB1 protein | 24898257 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased phosphorylation of RPS6 protein | 24898257 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein] | 24898257 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of HRAS mRNA" | 21346803 |
| C502239 | 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct] which results in increased mutagenesis of HRAS gene" | 12507937 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of HRAS mRNA" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of HRAS protein" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HRAS gene" | 15132766 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased abundance of Reactive Oxygen Species]" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of NOX1 protein]" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased phosphorylation of MAPK1 protein]" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased phosphorylation of MAPK3 protein]" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "HRAS protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 22307971 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct] which results in increased mutagenesis of HRAS gene" | 12507937 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of and results in increased activity of HRAS" | 8039140 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HRAS gene" | 11165753|9433479 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HRAS gene] which results in increased activity of HRAS protein" | 9433479|9433479 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "Dietary Fats affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HRAS gene]" | 9433479 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in increased activity of HRAS" | 1540938 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in increased mutagenesis of HRAS" | 1540938 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in increased mutagenesis of HRAS gene" | 8844820 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased mutagenesis of HRAS gene" | 2009133 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "2-amino-3-methylimidazo(4,5-f)quinoline results in increased mutagenesis of HRAS gene" | 2009133|8844820 |
| C004726 | 2-dichlorobenzene | 2-dichlorobenzene results in increased expression of HRAS mRNA | 10614693 |
| C004369 | 2-phenylphenol | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene | 10334203 |
| C004369 | 2-phenylphenol | bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| C004369 | 2-phenylphenol | CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene inhibits the reaction [HRAS protein results in increased activity of MMP2 protein]" | 23877152 |
| C025160 | 3-aminobenzamide | 3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of HRAS protein] | 26047893 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | "4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased activity of HRAS protein]" | 19133285 |
| C006757 | 4-biphenylamine | 4-biphenylamine results in increased mutagenesis of HRAS gene | 15761837 |
| C024836 | 4-nitrophenol | HRAS protein affects the glucuronidation of 4-nitrophenol | 11695553 |
| C080417 | 4-octylphenol | "4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]" | 12117780 |
| C067134 | 8-oxo-7-hydrodeoxyguanosine | HRAS protein mutant form results in increased abundance of 8-oxo-7-hydrodeoxyguanosine | 27517622 |
| C067134 | 8-oxo-7-hydrodeoxyguanosine | PRDX1 protein inhibits the reaction [HRAS protein mutant form results in increased abundance of 8-oxo-7-hydrodeoxyguanosine] | 27517622 |
| C503142 | ABT-100 | ABT-100 results in decreased farnesylation of HRAS protein | 15930366 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of HRAS mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased activity of HRAS protein | 19739265 |
| D000082 | Acetaminophen | Gliotoxin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] | 19739265 |
| D000082 | Acetaminophen | manumycin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] | 19739265 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [HRAS protein mutant form results in increased susceptibility to sodium arsenite] | 25199681 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] | 15945272 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of HRAS mRNA | 28959563 |
| D000244 | Adenosine Diphosphate | Adenosine Diphosphate binds to and affects the folding of HRAS protein | 16388579 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of HRAS protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of HRAS mRNA | 22100608|2715375 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of HRAS mRNA | 19770486 |
| D019386 | Alendronate | Alendronate results in decreased prenylation of HRAS protein | 9556058 |
| C010845 | aluminum chloride | aluminum chloride results in increased expression of HRAS mRNA | 22079183 |
| C000228 | aristolochic acid I | aristolochic acid I results in increased mutagenesis of HRAS gene | 21642617 |
| D001151 | Arsenic | Arsenic affects the methylation of HRAS gene | 25304211 |
| C006632 | arsenic trioxide | [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA | 18922899 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in decreased expression of HRAS protein" | 21570478 |
| D001218 | Aspartame | Aspartame results in increased expression of HRAS | 17354619 |
| D001280 | Atrazine | Atrazine results in decreased expression of HRAS mRNA | 22378314 |
| D001397 | Azoxymethane | Azoxymethane results in increased activity of HRAS protein | 12839936 |
| D001397 | Azoxymethane | Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased activity of HRAS protein] | 12839936 |
| C002478 | bathocuproine | bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| C002478 | bathocuproine | bathocuproine inhibits the reaction [[phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| C018003 | benzo(a)pyrene-3,6-quinone | "benzo(a)pyrene-3,6-quinone results in increased expression of HRAS mRNA" | 11008122 |
| C017228 | benzo(a)pyrene 7,8-dihydrodiol | "benzo(a)pyrene 7,8-dihydrodiol results in increased expression of HRAS mRNA" | 11008122 |
| C002615 | benzo(c)phenanthrene | benzo(c)phenanthrene analog results in increased mutagenesis of HRAS gene | 7955041 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene metabolite results in increased expression of HRAS mRNA | 11008122 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of HRAS mRNA | 11008122|2163298 |
| D001564 | Benzo(a)pyrene | HRAS mRNA results in increased susceptibility to Benzo(a)pyrene | 22048643 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with Tetradecanoylphorbol Acetate] affects the mutagenesis of HRAS gene | 11765016 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of HRAS mRNA | 22228805 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of HRAS mRNA | 18656336|2050435 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of HRAS protein | 18656336 |
| D001564 | Benzo(a)pyrene | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of HRAS mRNA | 25820237 |
| D001564 | Benzo(a)pyrene | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 18656336 |
| D001564 | Benzo(a)pyrene | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 18656336 |
| D001564 | Benzo(a)pyrene | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 18656336 |
| D001564 | Benzo(a)pyrene | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 18656336 |
| D001564 | Benzo(a)pyrene | theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 18656336 |
| D001564 | Benzo(a)pyrene | theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 18656336 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of HRAS mRNA | 19408242|2006408 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of HRAS protein | 19408242|2006408 |
| D001564 | Benzo(a)pyrene | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA | 19408242 |
| D001564 | Benzo(a)pyrene | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS protein | 19408242 |
| D001564 | Benzo(a)pyrene | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 20064080 |
| D001564 | Benzo(a)pyrene | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 20064080 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HRAS mRNA" | 18567617 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HRAS protein" | 18567617 |
| D001585 | Benzoyl Peroxide | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of HRAS mRNA" | 3115617 |
| D001585 | Benzoyl Peroxide | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased mutagenesis of HRAS gene" | 11241758|3115617 |
| D001585 | Benzoyl Peroxide | Benzoyl Peroxide results in increased mutagenesis of HRAS gene | 11241758 |
| D001608 | Beryllium | Beryllium results in increased mutagenesis of HRAS gene | 7545909 |
| D004958 | Estradiol | dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] | 16051634 |
| D004958 | Estradiol | Estradiol affects the expression of HRAS mRNA | 21826169 |
| D004958 | Estradiol | "Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]" | 12117780 |
| D004958 | Estradiol | Estradiol results in increased expression of HRAS mRNA | 16051634|2309414 |
| D004958 | Estradiol | Estradiol results in increased expression of HRAS mRNA | 22467019 |
| C477843 | bicyclol | bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA] | 17106253 |
| C006780 | bisphenol A | bisphenol A affects the expression of HRAS mRNA | 21826169 |
| C487933 | BMS225975 | BMS225975 results in decreased farnesylation of HRAS protein | 18230616 |
| D000069286 | Bortezomib | ATG5 gene mutant form inhibits the reaction [HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein]] | 22842577 |
| D000069286 | Bortezomib | HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein] | 22842577 |
| D002084 | Butylated Hydroxytoluene | HRAS protein results in increased susceptibility to Butylated Hydroxytoluene | 11599794 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in decreased methylation of HRAS gene | 9780227 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of HRAS protein | 23376331 |
| D019256 | Cadmium Chloride | HRAS protein mutant form affects the reaction [Cadmium Chloride results in decreased activity of CASP3 protein] | 23376331 |
| D019256 | Cadmium Chloride | HRAS protein mutant form affects the susceptibility to Cadmium Chloride | 23376331 |
| D002110 | Caffeine | "[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS mRNA" | 20230807 |
| D002110 | Caffeine | "Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HRAS mRNA]" | 20230807 |
| D000001 | Calcimycin | Calcimycin promotes the reaction [RASGRF2 protein binds to HRAS protein] | 16000378 |
| D000069287 | Capecitabine | HRAS protein results in decreased susceptibility to Capecitabine | 16734730 |
| D002211 | Capsaicin | Capsaicin results in increased expression of HRAS mRNA | 9461043 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of HRAS mRNA | 24752500 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of HRAS mRNA | 8847708 |
| D002273 | Carcinogens | Carcinogens results in increased expression of HRAS mRNA | 2228319 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA | 18636392 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of HRAS mRNA | 8471063 |
| D002737 | Chloroprene | Chloroprene results in increased mutagenesis of HRAS gene | 11397402 |
| C074702 | chromium hexavalent ion | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of HRAS mRNA | 25820237 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of HRAS mRNA | 18353800 |
| D009243 | NAD | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene | 10334203 |
| D009243 | NAD | bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| D009243 | NAD | CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| D003300 | Copper | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene | 10334203 |
| D003300 | Copper | bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| D003300 | Copper | bathocuproine inhibits the reaction [[phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| D003300 | Copper | CAT protein inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| D003300 | Copper | CAT protein inhibits the reaction [[phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| D003300 | Copper | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | 11275476 |
| D003300 | Copper | [phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene | 10334203 |
| D003300 | Copper | "[Copper co-treated with 1,2-diphenylhydrazine] results in increased mutagenesis of HRAS gene" | 10798712 |
| D003300 | Copper | "piperidine promotes the reaction [[Copper co-treated with 1,2-diphenylhydrazine] results in increased mutagenesis of HRAS gene]" | 10798712 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of HRAS mRNA | 19549813 |
| D003401 | Creatine | Creatine results in decreased expression of HRAS protein modified form | 15578723 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of HRAS mRNA | 25562108 |
| D003609 | Dactinomycin | Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] | 9345283 |
| C014347 | decitabine | decitabine results in decreased expression of HRAS mRNA | 19027819 |
| D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased activity of HRAS protein | 18444174 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]] | 10807665 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]] | 10807665 |
| C061481 | dibenzoylmethane | dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] | 16051634 |
| D002945 | Cisplatin | Cisplatin affects the splicing of HRAS mRNA | 23613995 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [jinfukang results in increased expression of HRAS mRNA] | 27392435 |
| D002945 | Cisplatin | HRAS results in decreased susceptibility to Cisplatin | 21849418 |
| D002945 | Cisplatin | jinfukang promotes the reaction [Cisplatin results in increased expression of HRAS mRNA] | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of HRAS mRNA | 25270620 |
| D002945 | Cisplatin | Cisplatin results in increased expression of HRAS mRNA | 18172885 |
| D004008 | Diclofenac | Diclofenac affects the expression of HRAS mRNA | 24752500 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of HRAS mRNA | 25016146 |
| D004041 | Dietary Fats | "Dietary Fats affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HRAS gene]" | 9433479 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of HRAS mRNA | 28085963 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with HRAS protein] results in increased activity of GOT1 protein | 12499697 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with HRAS protein] results in increased activity of MDH1 protein | 12499697 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of HRAS mRNA | 26464624 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased mutagenesis of HRAS gene | 15592514|2453584 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of HRAS mRNA | 18978307 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of HRAS mRNA | 7910516 |
| C015835 | dimethyl-4-toluidine | dimethyl-4-toluidine results in decreased expression of HRAS mRNA | 27638505 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]" | 12117780 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]" | 12117780 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene" | 11376698|1211778 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of HRAS mRNA" | 3115617 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased mutagenesis of HRAS gene" | 11241758|3115617 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS mRNA" | 3115617 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HRAS mRNA" | 3115617 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene" | 11241758|3115617 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene" | 1375869|20103723 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide affects the expression of HRAS mRNA | 24834073 |
| C067311 | docetaxel | docetaxel results in increased expression of and results in increased activity of HRAS protein | 15970518 |
| C025034 | doxifluridine | HRAS protein results in decreased susceptibility to doxifluridine | 16734730 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of HRAS protein] | 26047893 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of HRAS mRNA | 16001973 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in decreased mutagenesis of HRAS gene" | 23262642 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in decreased expression of HRAS mRNA" | 12747207 |
| D004610 | Ellagic Acid | "[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D004610 | Ellagic Acid | "[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D004791 | Enzyme Inhibitors | [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] inhibits the reaction [HRAS protein binds to Guanosine Triphosphate] | 25825487 |
| D004791 | Enzyme Inhibitors | [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] promotes the reaction [HRAS protein binds to Guanosine Diphosphate] | 25825487 |
| D004791 | Enzyme Inhibitors | Enzyme Inhibitors inhibits the reaction [SOS1 protein binds to [HRAS protein binds to Guanosine Diphosphate]] | 25825487 |
| C062669 | epicatechin gallate | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 18656336 |
| C062669 | epicatechin gallate | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 18656336 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 18656336 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 18656336 |
| C500988 | estradiol-3,4-quinone | "estradiol-3,4-quinone results in increased mutagenesis of HRAS gene" | 17261777 |
| C500988 | estradiol-3,4-quinone | "estradiol-3,4-quinone results in increased mutagenesis of HRAS gene" | 17261777 |
| D004967 | Estrogens | [Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA | 18204794 |
| D004967 | Estrogens | [Parathion co-treated with Estrogens] results in increased expression of HRAS mRNA | 18204794 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of HRAS mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HRAS mRNA | 17942748 |
| C024565 | ethylene dichloride | HRAS protein results in increased susceptibility to ethylene dichloride | 28421967 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of HRAS mRNA | 23649840 |
| D005038 | Ethylnitrosourea | HRAS protein results in increased susceptibility to Ethylnitrosourea | 11182032 |
| D005038 | Ethylnitrosourea | HRAS protein results in increased susceptibility to Ethylnitrosourea | 26558449 |
| D005054 | Eugenol | Eugenol results in decreased expression of HRAS protein | 20537511 |
| D005200 | FANFT | FANFT results in increased expression of HRAS mRNA | 3433577 |
| C004808 | farnesyl pyrophosphate | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | 18625914 |
| C004808 | farnesyl pyrophosphate | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] | 18625914 |
| C093323 | farnesylthiosalicylic acid | farnesylthiosalicylic acid results in decreased activity of HRAS protein | 15328380 |
| C093323 | farnesylthiosalicylic acid | farnesylthiosalicylic acid results in decreased expression of HRAS protein | 16780807 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of HRAS mRNA | 18978307 |
| C020748 | ferrous sulfate | ferrous sulfate affects the localization of HRAS protein | 17172471 |
| C020748 | ferrous sulfate | ferrous sulfate promotes the reaction [MAP3K7 protein binds to HRAS protein binds to PIK3R1 protein] | 17172471 |
| C020748 | ferrous sulfate | HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | 17172471 |
| C020748 | ferrous sulfate | HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | 17172471 |
| C020748 | ferrous sulfate | HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of MAPK3 protein] | 17172471 |
| C020748 | ferrous sulfate | HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of NFKBIA protein] | 17172471 |
| D018120 | Finasteride | Finasteride results in increased expression of HRAS mRNA | 24136188 |
| C082360 | fipronil | fipronil results in decreased expression of HRAS mRNA | 23962444 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of HRAS protein | 11350689 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of HRAS mRNA | 16557594 |
| D005480 | Flurbiprofen | HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] | 16949054 |
| D005485 | Flutamide | Flutamide results in increased expression of HRAS mRNA | 24136188 |
| D005492 | Folic Acid | Folic Acid results in increased expression of HRAS mRNA | 2566606 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of HRAS mRNA | 23649840 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of HRAS mRNA | 9149109 |
| C017338 | geranylgeraniol | geranylgeraniol promotes the reaction [Lovastatin results in decreased farnesylation of HRAS protein] | 9018116 |
| C002963 | geranylgeranyl pyrophosphate | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | 18625914 |
| D005897 | Glafenine | Glafenine results in increased expression of HRAS mRNA | 24136188 |
| D005912 | Gliotoxin | Gliotoxin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] | 19739265 |
| D005947 | Glucose | Glucose results in increased activity of HRAS protein | 16572112 |
| D005947 | Glucose | manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] | 16572112 |
| D005978 | Glutathione | Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] | 9345283 |
| D005978 | Glutathione | [Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene | 9345283 |
| D006034 | Glycyrrhetinic Acid | Glycyrrhetinic Acid results in decreased expression of HRAS protein | 19958823 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [lead acetate results in increased activity of HRAS protein] | 19133285 |
| D006153 | Guanosine Diphosphate | [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] promotes the reaction [HRAS protein binds to Guanosine Diphosphate] | 25825487 |
| D006153 | Guanosine Diphosphate | Enzyme Inhibitors inhibits the reaction [SOS1 protein binds to [HRAS protein binds to Guanosine Diphosphate]] | 25825487 |
| D006160 | Guanosine Triphosphate | [Enzyme Inhibitors binds to and results in decreased activity of SOS1 protein] inhibits the reaction [HRAS protein binds to Guanosine Triphosphate] | 25825487 |
| D005937 | Glucaric Acid | "[Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D005937 | Glucaric Acid | "[Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of CDK1 mRNA] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of CDK1 protein] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of CENPA protein] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of CHEK1 mRNA] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of CHEK1 protein] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of H2AFZ mRNA] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of H2AFZ protein] | 22473992 |
| C479979 | GW0742 | [GW0742 binds to and results in increased activity of PPARD protein] inhibits the reaction [HRAS protein results in increased expression of NEK2 protein] | 22473992 |
| D006533 | Heptachlor | Heptachlor results in decreased expression of HRAS mRNA | 1771636 |
| C089796 | hexabromocyclododecane | hexabromocyclododecane results in increased expression of HRAS mRNA | 19027819 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of HRAS mRNA | 16467112 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of HRAS mRNA | 11008122 |
| D006861 | Hydrogen Peroxide | HRAS protein affects the susceptibility to [Hydrogen Peroxide results in increased activity of MAPK1 protein] | 14975446 |
| D006861 | Hydrogen Peroxide | HRAS protein affects the susceptibility to [Hydrogen Peroxide results in increased activity of MAPK3 protein] | 14975446 |
| C031927 | hydroquinone | 3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of HRAS protein] | 26047893 |
| C031927 | hydroquinone | Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of HRAS protein] | 26047893 |
| C031927 | hydroquinone | hydroquinone affects the expression of HRAS mRNA | 26047893 |
| C031927 | hydroquinone | hydroquinone affects the expression of HRAS protein | 26047893 |
| C031927 | hydroquinone | hydroquinone promotes the reaction [PARP1 protein binds to and results in increased ADP-ribosylation of and results in increased expression of HRAS protein] | 26047893 |
| C031927 | hydroquinone | PARP1 protein promotes the reaction [hydroquinone results in increased expression of HRAS protein] | 26047893 |
| C073007 | ibandronic acid | ibandronic acid results in decreased prenylation of HRAS protein | 9556058 |
| D019807 | Iodoacetic Acid | HRAS protein modified form results in increased susceptibility to Iodoacetic Acid | 19923925 |
| D007501 | Iron | HRAS protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] | 17172471 |
| D007501 | Iron | HRAS protein affects the reaction [Iron results in increased phosphorylation of MAPK1 protein] | 17172471 |
| D007501 | Iron | HRAS protein affects the reaction [Iron results in increased phosphorylation of MAPK3 protein] | 17172471 |
| D007501 | Iron | HRAS protein affects the reaction [Iron results in increased phosphorylation of NFKBIA protein] | 17172471 |
| D007501 | Iron | Iron affects the localization of HRAS protein | 17172471 |
| D007501 | Iron | Iron promotes the reaction [MAP3K7 protein binds to HRAS protein binds to PIK3R1 protein] | 17172471 |
| C005059 | isoprene | isoprene results in increased mutagenesis of HRAS gene | 11397402|9111215 |
| D007545 | Isoproterenol | Isoproterenol results in increased activity of HRAS protein | 8484791 |
| C544151 | jinfukang | Cisplatin promotes the reaction [jinfukang results in increased expression of HRAS mRNA] | 27392435 |
| C544151 | jinfukang | jinfukang promotes the reaction [Cisplatin results in increased expression of HRAS mRNA] | 27392435 |
| C410337 | K 7174 | K 7174 results in decreased expression of HRAS mRNA | 24086573 |
| D007649 | Ketamine | Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS protein] | 19540866 |
| C096898 | L 744832 | L 744832 results in decreased prenylation of HRAS protein | 16156861 |
| D007854 | Lead | Lead affects the splicing of HRAS mRNA | 28903495 |
| D007854 | Lead | Lead inhibits the reaction [HSPA5 protein binds to HRAS enhancer] | 15111246 |
| C008261 | lead acetate | "4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased activity of HRAS protein]" | 19133285 |
| C008261 | lead acetate | Go 6976 inhibits the reaction [lead acetate results in increased activity of HRAS protein] | 19133285 |
| C008261 | lead acetate | HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein] | 19133285 |
| C008261 | lead acetate | HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein] | 19133285 |
| C008261 | lead acetate | HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of RAF1 protein] | 19133285 |
| C008261 | lead acetate | lead acetate results in increased activity of HRAS protein | 19133285 |
| C008261 | lead acetate | PRKCA mutant form inhibits the reaction [lead acetate results in increased activity of HRAS protein] | 19133285 |
| C008261 | lead acetate | SU 6656 inhibits the reaction [lead acetate results in increased activity of HRAS protein] | 19133285 |
| C008261 | lead acetate | lead acetate inhibits the reaction [HSPA5 protein binds to HRAS enhancer] | 15111246 |
| C008281 | limonene | limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] | 11802805 |
| D008070 | Lipopolysaccharides | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | 18625914 |
| D008070 | Lipopolysaccharides | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] | 18625914 |
| D008070 | Lipopolysaccharides | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | 18625914 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of HRAS protein | 18625914 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased localization of HRAS protein | 18625914 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased prenylation of HRAS protein | 18625914 |
| D008070 | Lipopolysaccharides | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein] | 18625914 |
| D008070 | Lipopolysaccharides | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein] | 18625914 |
| D008070 | Lipopolysaccharides | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased prenylation of HRAS protein] | 18625914 |
| D008070 | Lipopolysaccharides | Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS protein] | 19540866 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS protein | 19540866 |
| D008070 | Lipopolysaccharides | TLR4 mutant form inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein] | 19540866 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased activity of HRAS protein] | 15090542 |
| D008148 | Lovastatin | Lovastatin results in decreased prenylation of and results in decreased localization of HRAS protein | 19360310 |
| D008148 | Lovastatin | Lovastatin results in decreased prenylation of HRAS protein | 16156861 |
| D008148 | Lovastatin | geranylgeraniol promotes the reaction [Lovastatin results in decreased farnesylation of HRAS protein] | 9018116 |
| D008148 | Lovastatin | Lovastatin results in decreased farnesylation of HRAS protein | 9018116 |
| D008294 | Malathion | [Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA | 18204794 |
| D008294 | Malathion | Malathion results in increased expression of HRAS mRNA | 18204794 |
| D008294 | Malathion | Malathion results in increased expression of HRAS protein | 19787260 |
| C054474 | manumycin | manumycin results in decreased expression of HRAS protein | 19958823 |
| C054474 | manumycin | manumycin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein] | 19739265 |
| C054474 | manumycin | manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] | 16572112 |
| C054474 | manumycin | manumycin results in decreased farnesylation of HRAS protein | 21211511 |
| D008627 | Mercuric Chloride | Mercuric Chloride promotes the reaction [HSPA5 protein binds to HRAS enhancer] | 15111246 |
| D008628 | Mercury | Mercury promotes the reaction [HSPA5 protein binds to HRAS enhancer] | 15111246 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of HRAS mRNA | 15644446 |
| D008731 | Methoxychlor | Methoxychlor results in decreased expression of HRAS mRNA | 23303685 |
| D008731 | Methoxychlor | Methoxychlor results in increased methylation of HRAS gene | 23303685 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased activity of HRAS protein | 28837763 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of HRAS mRNA | 23649840 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein] | 15708576 |
| D008770 | Methylnitrosourea | HRAS protein results in increased susceptibility to Methylnitrosourea | 11182032|1137669 |
| D008770 | Methylnitrosourea | limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] | 11802805 |
| D008770 | Methylnitrosourea | HRAS protein results in increased susceptibility to Methylnitrosourea | 28421967 |
| D008770 | Methylnitrosourea | HRAS protein results in decreased susceptibility to Methylnitrosourea | 11973638 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased mutagenesis of HRAS gene | 10767621|1568839 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HRAS mRNA" | 20230807 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS mRNA" | 20230807 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HRAS mRNA]" | 20230807 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS mRNA" | 20230807 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HRAS mRNA]" | 20230807 |
| C011309 | mezerein | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS mRNA" | 3115617 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]] | 10807665 |
| C040015 | myricetin | myricetin results in decreased activity of HRAS protein | 17693661 |
| C058346 | N-(4-methoxyphenyl)retinamide | N-(4-methoxyphenyl)retinamide results in decreased expression of HRAS mRNA | 16467112 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of HRAS mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of HRAS mRNA | 20551477 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein] | 18296682 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in decreased expression of CDK4 protein] | 18296682 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in increased expression of CDKN1A protein] | 18296682 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein] | 18296682 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein] | 18296682 |
| C005274 | naringin | naringin results in increased activity of HRAS protein | 18296682 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein] | 18951945 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in decreased expression of CDK4 protein] | 18951945 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in increased expression of CDKN1A protein] | 18951945 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein] | 18951945 |
| C005274 | naringin | HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein] | 18951945 |
| C005274 | naringin | naringin results in increased activity of HRAS protein | 18951945 |
| C014593 | N-hydroxy-4-aminobiphenyl | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | 11275476 |
| D009538 | Nicotine | "[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS mRNA" | 20230807 |
| D009538 | Nicotine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HRAS mRNA]" | 20230807 |
| D009538 | Nicotine | Nicotine results in increased activity of HRAS protein | 15983034 |
| C012655 | nimesulide | nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA] | 20043093 |
| C012655 | nimesulide | nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] | 20043093 |
| D009583 | Nitrofurazone | Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] | 15945272 |
| D009583 | Nitrofurazone | Nitrofurazone results in increased expression of HRAS mRNA | 15945272 |
| D015112 | 4-Nitroquinoline-1-oxide | [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA | 20043093 |
| D015112 | 4-Nitroquinoline-1-oxide | [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA | 20043093 |
| D015112 | 4-Nitroquinoline-1-oxide | nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA] | 20043093 |
| D015112 | 4-Nitroquinoline-1-oxide | nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] | 20043093 |
| D009705 | Nucleosides | Nucleosides results in increased expression of HRAS mRNA | 15173389 |
| C464660 | obeticholic acid | obeticholic acid results in decreased expression of HRAS mRNA | 27939613 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of HRAS mRNA | 23358140 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA | 18636392 |
| D010269 | Paraquat | Paraquat affects the splicing of HRAS mRNA | 23613995 |
| D010278 | Parathion | [Parathion co-treated with Estrogens] results in increased expression of HRAS mRNA | 18204794 |
| D010278 | Parathion | Parathion results in increased expression of HRAS protein | 19787260 |
| C011272 | perfosfamide | perfosfamide results in decreased expression of HRAS mRNA | 19429390 |
| D010634 | Phenobarbital | Phenobarbital results in decreased mutagenesis of HRAS protein | 11753661 |
| C066330 | phenylhydroquinone | bathocuproine inhibits the reaction [[phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| C066330 | phenylhydroquinone | CAT protein inhibits the reaction [[phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene] | 10334203 |
| C066330 | phenylhydroquinone | [phenylhydroquinone co-treated with Copper] results in increased mutagenesis of HRAS gene | 10334203 |
| D010695 | Phlorhizin | Phlorhizin results in increased expression of HRAS mRNA | 22538082 |
| C032727 | piperidine | "piperidine promotes the reaction [[Copper co-treated with 1,2-diphenylhydrazine] results in increased mutagenesis of HRAS gene]" | 10798712 |
| D010936 | Plant Extracts | "[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D010936 | Plant Extracts | "[Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D010936 | Plant Extracts | Plant Extracts results in decreased mutagenesis of HRAS gene | 23262642 |
| D010936 | Plant Extracts | "[resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| D011005 | Plutonium | Plutonium results in increased mutagenesis of HRAS gene | 9255578 |
| D011374 | Progesterone | Progesterone results in increased expression of HRAS mRNA | 21549006 |
| D011765 | Pyruvaldehyde | Pyruvaldehyde results in increased activity of HRAS protein | 17635749 |
| D011794 | Quercetin | Quercetin results in decreased expression of HRAS mRNA | 10652438 |
| D011794 | Quercetin | Quercetin results in decreased expression of HRAS protein | 10652438 |
| D011794 | Quercetin | Quercetin results in increased expression of HRAS mRNA | 21632981 |
| D017382 | Reactive Oxygen Species | HRAS protein affects the abundance of Reactive Oxygen Species | 22307971 |
| D017382 | Reactive Oxygen Species | "HRAS protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased abundance of Reactive Oxygen Species]" | 22307971 |
| D017382 | Reactive Oxygen Species | HRAS protein mutant form results in increased abundance of Reactive Oxygen Species | 27517622 |
| D017382 | Reactive Oxygen Species | PRDX1 protein inhibits the reaction [HRAS protein mutant form results in increased abundance of Reactive Oxygen Species] | 27517622 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK3 protein] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased expression of and results in increased phosphorylation of TP53 protein] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased expression of CDKN1A mRNA] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased expression of TP53 mRNA] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK1 protein] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of MAPK3 protein] | 11889192 |
| C059514 | resveratrol | HRAS protein promotes the reaction [TP53 protein results in increased susceptibility to resveratrol] | 11889192 |
| C059514 | resveratrol | resveratrol affects the expression of HRAS mRNA mutant form | 16369916 |
| C059514 | resveratrol | resveratrol affects the expression of HRAS protein mutant form | 16369916 |
| C059514 | resveratrol | "[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| C059514 | resveratrol | "[Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| C059514 | resveratrol | "[resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]" | 20103723 |
| C059514 | resveratrol | resveratrol results in decreased activity of HRAS protein mutant form | 10910059 |
| D000068296 | Risedronate Sodium | Risedronate Sodium results in decreased prenylation of HRAS protein | 9556058 |
| D012402 | Rotenone | Rotenone results in decreased expression of HRAS mRNA | 10630619 |
| C079198 | S 1 (combination) | HRAS protein results in decreased susceptibility to S 1 (combination) | 16734730 |
| C111350 | Sch 59228 | Sch 59228 results in decreased prenylation of HRAS protein | 9923541 |
| D012643 | Selenium | [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA | 19244175 |
| D012643 | Selenium | Selenium results in increased expression of HRAS mRNA | 19244175 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of HRAS protein" | 10905503 |
| D017632 | Asbestos, Serpentine | "tobacco tar promotes the reaction [Asbestos, Serpentine results in increased expression of HRAS protein]" | 10905503 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of HRAS mRNA | 25895662 |
| D019821 | Simvastatin | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | 18625914 |
| D019821 | Simvastatin | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]] | 18625914 |
| D019821 | Simvastatin | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | 18625914 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein] | 18625914 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein] | 18625914 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased prenylation of HRAS protein] | 18625914 |
| D019821 | Simvastatin | Simvastatin results in decreased prenylation of and results in decreased localization of HRAS protein | 19360310 |
| D019821 | Simvastatin | Simvastatin results in decreased activity of HRAS | 11914545 |
| C024711 | siomycin A | siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of CCND1 protein] | 27517622 |
| C024711 | siomycin A | siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of FOXM1 protein] | 27517622 |
| C024711 | siomycin A | siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of NFE2L2 protein] | 27517622 |
| C024711 | siomycin A | siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of PRDX1 protein] | 27517622 |
| D020123 | Sirolimus | PPARD protein affects the reaction [[Sirolimus co-treated with HRAS protein] results in decreased expression of ERN1 protein] | 24898257 |
| D020123 | Sirolimus | PPARD protein affects the reaction [[Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein] | 24898257 |
| D020123 | Sirolimus | [Sirolimus co-treated with HRAS protein] results in decreased expression of ERN1 protein | 24898257 |
| D020123 | Sirolimus | [Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein | 24898257 |
| C017947 | sodium arsenite | Acetylcysteine inhibits the reaction [HRAS protein mutant form results in increased susceptibility to sodium arsenite] | 25199681 |
| C017947 | sodium arsenite | HRAS protein mutant form results in increased susceptibility to sodium arsenite | 25199681 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [HRAS protein mutant form results in increased activity of CAT protein] | 25199681 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of HRAS mRNA | 19464579 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of HRAS protein | 16039940 |
| C017947 | sodium arsenite | HRAS gene mutant form results in increased susceptibility to sodium arsenite | 22700541 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of HRAS mRNA | 19822182 |
| C017947 | sodium arsenite | sodium arsenite results in decreased methylation of HRAS promoter | 12016150 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of HRAS mRNA | 14691202 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of HRAS mRNA | 11241755|1687621 |
| C416927 | SU 6656 | SU 6656 inhibits the reaction [lead acetate results in increased activity of HRAS protein] | 19133285 |
| D013458 | Sulfur Dioxide | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA | 19408242 |
| D013458 | Sulfur Dioxide | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS protein | 19408242 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 20064080 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 20064080 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of HRAS mRNA | 19408242|2006408 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of HRAS protein | 19408242|2006408 |
| C452601 | sulindac derivative IND 12 | HRAS protein affects the reaction [sulindac derivative IND 12 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | 11912145 |
| C452601 | sulindac derivative IND 12 | HRAS protein affects the reaction [sulindac derivative IND 12 results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | 11912145 |
| D013481 | Superoxides | HRAS protein mutant form results in increased abundance of Superoxides | 11313892 |
| D013481 | Superoxides | [HRAS protein mutant form results in increased abundance of Superoxides] which results in decreased susceptibility to TNF protein | 11313892 |
| D013739 | Testosterone | Testosterone results in decreased expression of HRAS mRNA | 20403060 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of HRAS protein | 9707505 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HRAS mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of HRAS mRNA | 21354282 |
| D013755 | Tetradecanoylphorbol Acetate | HRAS protein affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of CDH5 protein] | 24211779 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA | 18922899 |
| D013755 | Tetradecanoylphorbol Acetate | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS mRNA" | 3115617 |
| D013755 | Tetradecanoylphorbol Acetate | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HRAS mRNA" | 3115617 |
| D013755 | Tetradecanoylphorbol Acetate | "[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene" | 11241758|3115617 |
| D013755 | Tetradecanoylphorbol Acetate | [Benzo(a)pyrene co-treated with Tetradecanoylphorbol Acetate] affects the mutagenesis of HRAS gene | 11765016 |
| D013755 | Tetradecanoylphorbol Acetate | bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA] | 17106253 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA | 17106253 |
| D013755 | Tetradecanoylphorbol Acetate | [Zidovudine co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene | 9766437 |
| D013774 | Tetranitromethane | Tetranitromethane results in increased mutagenesis of HRAS gene | 9255578 |
| D019284 | Thapsigargin | [Thapsigargin co-treated with HRAS protein] results in decreased phosphorylation of MAPK1 protein | 24898257 |
| D019284 | Thapsigargin | [Thapsigargin co-treated with HRAS protein] results in decreased phosphorylation of MAPK3 protein | 24898257 |
| D019284 | Thapsigargin | [Thapsigargin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein | 24898257 |
| D019284 | Thapsigargin | [Thapsigargin co-treated with HRAS protein] results in increased expression of ERN1 protein | 24898257 |
| D019284 | Thapsigargin | [Thapsigargin co-treated with HRAS protein] results in increased expression of HSPA5 protein | 24898257 |
| D019284 | Thapsigargin | [Thapsigargin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein | 24898257 |
| C056068 | theaflavin | theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | 18656336 |
| C056068 | theaflavin | theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | 18656336 |
| C402769 | tipifarnib | tipifarnib results in decreased metabolism of HRAS protein | 15728126 |
| C402769 | tipifarnib | HRAS gene mutant form results in increased susceptibility to tipifarnib | 16403772|1664857 |
| C402769 | tipifarnib | tipifarnib results in decreased activity of HRAS protein | 15970518 |
| C024746 | tobacco tar | "tobacco tar promotes the reaction [Asbestos, Serpentine results in increased expression of HRAS protein]" | 10905503 |
| C113106 | tocopheryloxybutyric acid | tocopheryloxybutyric acid inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] | 11062179 |
| D014050 | Toluene | Toluene affects the expression of HRAS mRNA | 21827849 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of HRAS mRNA | 16604517 |
| C023764 | triciribine | triciribine inhibits the reaction [HRAS protein results in increased activity of MMP2 protein] | 23877152 |
| C046488 | trimethyltin | trimethyltin results in increased expression of HRAS mRNA | 21435392 |
| C001899 | triptolide | triptolide results in decreased expression of HRAS mRNA | 23639586 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of HRAS mRNA" | 26179874 |
| C057693 | troglitazone | troglitazone promotes the reaction [HRAS protein results in increased susceptibility to Urethane] | 26558449 |
| C057693 | troglitazone | troglitazone results in increased expression of HRAS mRNA | 17569031 |
| D014415 | Tunicamycin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein] | 24898257 |
| D014415 | Tunicamycin | HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein] | 24898257 |
| D014415 | Tunicamycin | HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein] | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK1 protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK3 protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in increased expression of ERN1 protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in increased expression of HSPA5 protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein | 24898257 |
| D014415 | Tunicamycin | [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein | 24898257 |
| C113580 | U 0126 | U 0126 inhibits the reaction [HRAS protein results in increased expression of PMAIP1 protein] | 20802529 |
| D014520 | Urethane | HRAS protein promotes the reaction [Urethane results in increased expression of CCND1 protein] | 11307925 |
| D014520 | Urethane | HRAS protein results in increased susceptibility to Urethane | 10779650|1155229 |
| D014520 | Urethane | Urethane results in increased mutagenesis of HRAS gene | 10779650|1276524 |
| D014520 | Urethane | HRAS protein promotes the reaction [Urethane results in increased expression of AURKB mRNA] | 26558449 |
| D014520 | Urethane | HRAS protein promotes the reaction [Urethane results in increased expression of CCNB1 mRNA] | 26558449 |
| D014520 | Urethane | HRAS protein promotes the reaction [Urethane results in increased expression of EREG mRNA] | 26558449 |
| D014520 | Urethane | HRAS protein results in increased susceptibility to Urethane | 15902970|2655844 |
| D014520 | Urethane | tocopheryloxybutyric acid inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] | 11062179 |
| D014520 | Urethane | troglitazone promotes the reaction [HRAS protein results in increased susceptibility to Urethane] | 26558449 |
| D014520 | Urethane | Urethane promotes the reaction [RAF1 protein binds to HRAS protein] | 11062179 |
| D014520 | Urethane | Urethane results in increased expression of HRAS mRNA | 18465119 |
| D014520 | Urethane | Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] | 11062179 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased activity of HRAS protein] | 12839936 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [EGF results in increased activity of HRAS protein] | 12839936 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of HRAS mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of HRAS mRNA | 23179753 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of HRAS gene | 29154799 |
| D014638 | Vanadates | HRAS protein mutant form results in increased susceptibility to Vanadates | 19167484 |
| D014638 | Vanadates | HRAS protein results in decreased susceptibility to Vanadates | 19167484 |
| D014638 | Vanadates | Vanadates results in increased expression of HRAS protein | 19167484 |
| D001335 | Vehicle Emissions | HRAS protein results in increased susceptibility to Vehicle Emissions | 11516524 |
| D014750 | Vincristine | Vincristine results in increased expression of HRAS mRNA | 16001973 |
| C017963 | vinyl carbamate | vinyl carbamate results in increased mutagenesis of HRAS gene | 12765245 |
| D014810 | Vitamin E | [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA | 19244175 |
| D014810 | Vitamin E | Vitamin E results in increased expression of HRAS mRNA | 19244175 |
| D014810 | Vitamin E | Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] | 11062179 |
| D014873 | Water Pollutants | Water Pollutants results in increased expression of HRAS mRNA | 23591932 |
| D015215 | Zidovudine | [Zidovudine co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene | 9766437 |
| D009353 | Zinostatin | Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] | 9345283 |
| D009353 | Zinostatin | [Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene | 9345283 |
| C088658 | zoledronic acid | zoledronic acid results in decreased localization of HRAS protein | 11986784 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of HRAS protein | 28871336 |